The Food and Drug Administration issued a limited emergency use authorization of two malaria drugs that have been pushed by President Trump for treating the coronavirus.
In a statement Sunday night, the Health and Human Services Department announced it had received 30 million doses of hydroxychloroquine sulfate and one million doses of chloroquine phosphate. The drugs were donated to the Strategic National Stockpile, a repository of potentially life-saving medical supplies.
The statement said the FDA had issued an emergency use authorization to allow both drugs “to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”
The Food and Drug Administration has approved a process that would clean much-needed N95 protective face masks and allow them to be reused, the agency said in a release. Columbus-Ohio based Battelle uses a “vapor phase hydrogen peroxide” process to decontaminate the masks being used by healthcare providers and others to protect against the spread of COVID-19. Battelle says its Critical Care Decontamination Systems could decontaminate up to 80,000 masks per day.
This helps front line health care workers, as there has been a shortage of disposable Personal Protective Equipment (PPE), including N95 masks.
Thank you for supporting FiberKind by turning off your ad blocker on this forum! We hand-pick all advertisements to be relevant to our shared love of crafting.
FiberKind LLC uses affiliate links and advertisements to fund FiberKind.com. When clicking on ads or links from FiberKind.com before shopping you are helping with the costs of running FiberKind.
Did you know Amazon is an affiliate? By clicking through our affiliate link you are helping support FiberKind at no cost to you. If you have questions about the Amazon or other affiliate advertising, please let @Char know.
